Engineering “smarter” cells, with Tim Lu
Traditional cell therapies rely on “clean targets” – antigens that are found on cancer cells but not on healthy cells. Where these targets can’t be found, it’s difficult to build a therapy that will deliver kill cancer cells without being too dangerous to other cells. Senti Bio is developing a solution to this problem: “logic-gated” cells which have multiple receptors allowing them to attack cancer cells while leaving healthy cells alone, even without a clean target. In San Francisco this month during JPM Editor in Chief Jonah Comstock caught up with Senti Bio CEO Tim Lu to discuss this…
